// App-Quantinova.ai

: The HORIZON III retrospective exploratory analysis: HER2 expression amplification in colorectal cancer.

Researchers

Presenter

  • Fabiola Cecchi

Principal Investigators

  • Natasha Viglianti

  • Marlon Rebelatto

  • Norah J Shire

  • Simon T Barry

  • Tsveta Milenkova

  • Elizabeth Croydon

  • Danielle Carroll

  • J Carl Barrett

Medical Centers

  • AstraZeneca, Waltham, MA

  • AstraZeneca Pharmaceuticals, Gaithersburg, MD

  • AstraZeneca Translational Medicine, Early Oncology, Gaithersburg, MD

  • AstraZeneca Pharmaceuticals, Cambridge, United Kingdom

  • AstraZeneca Translational Medicine, Early Oncology, Cambridge, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Gastric Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Bevacizumab

  • Cediranib

  • Oxaliplatin, 5-fluorouracil and folic acid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT00384176

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved